Nancy C Andrews insider trades: Charles River Laboratories International (CRL) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Nancy reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | CRL | ↓ Sell | 573 | $285.24 | $163K | Direct | Aug 20, 2026 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CRL insiders
Open-market trades in the last 12 months
About Nancy C Andrews's insider trades
Nancy C Andrews is a director at Charles River Laboratories International (CRL). Since Aug 18, 2026, Nancy has reported no open-market purchases and 1 sale worth $163K on SEC Form 4. In the last 12 months: 1 sale ($163K).
Their filings also include grants and awards (10 filings), option exercises (1 filing), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CRL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.